| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.94e-05 | 43 | 154 | 5 | GO:0030280 | |
| GeneOntologyMolecularFunction | actin binding | FLNA MYH13 IQGAP2 SYNE1 MYO18A IPP IQGAP1 LRPPRC DST MICAL2 DIAPH2 MYH15 CORO6 CROCC | 2.13e-05 | 479 | 154 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 6.88e-05 | 227 | 154 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | sterol response element binding | 1.76e-04 | 3 | 154 | 2 | GO:0032810 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | FLNA SPAST KIF27 MYH13 IQGAP2 CENPF SYNE1 MYO18A IPP FSD1 IQGAP1 LRPPRC DST MICAL2 CCSER2 DIAPH2 MYH15 CORO6 EML1 CROCC | 3.10e-04 | 1099 | 154 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 5.19e-04 | 130 | 154 | 6 | GO:0005200 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 4.70e-08 | 99 | 151 | 9 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 5.13e-08 | 100 | 151 | 9 | GO:0045103 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 7.63e-08 | 75 | 151 | 8 | GO:0045109 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | CYP1B1 KRT4 FLNA KRT5 KRT6A KRT6B KRT12 SPAST IQGAP2 DSP ARHGAP17 FSD1 IQGAP1 FAM171A1 KRT6C MICAL2 PDE4DIP DIAPH2 CORO6 KRT37 | 2.31e-05 | 957 | 151 | 20 | GO:0097435 |
| GeneOntologyBiologicalProcess | cilium assembly | FLNA TBC1D9B KIF27 TCHP SYNE1 LAMA5 RFX2 RFX3 DNAH7 ODF2L RP1L1 CROCC CEP97 | 2.43e-05 | 444 | 151 | 13 | GO:0060271 |
| GeneOntologyBiologicalProcess | cilium organization | FLNA TBC1D9B KIF27 TCHP SYNE1 LAMA5 RFX2 RFX3 DNAH7 ODF2L RP1L1 CROCC CEP97 | 4.97e-05 | 476 | 151 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 1.44e-04 | 108 | 151 | 6 | GO:1902017 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 1.59e-04 | 3 | 151 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 1.59e-04 | 3 | 151 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 1.59e-04 | 3 | 151 | 2 | GO:1902407 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT4 FLNA KRT5 KRT6A KRT6B MTMR12 KRT12 SPAST KIF27 MYH13 IQGAP2 TCHP DSP PYROXD1 SYNE1 MYO18A RIBC1 FSD1 DNAH7 IQGAP1 GRIP1 PARP4 LRPPRC DST KRT6C RTL1 MICAL2 RP1L1 PDE4DIP DIAPH2 PYGM MYH15 EML1 TUBE1 KRT37 | 6.43e-13 | 1179 | 152 | 35 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT4 FLNA KRT5 KRT6A KRT6B MTMR12 KRT12 SPAST KIF27 MYH13 IQGAP2 TCHP DSP PYROXD1 SYNE1 MYO18A RIBC1 FSD1 DNAH7 IQGAP1 GRIP1 PARP4 LRPPRC DST KRT6C RTL1 MICAL2 RP1L1 PDE4DIP DIAPH2 PYGM MYH15 EML1 TUBE1 KRT37 | 7.81e-13 | 1187 | 152 | 35 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT4 FLNA KRT5 KRT6A KRT6B KRT12 SPAST KIF27 IQGAP2 TCHP DSP RIBC1 FSD1 DNAH7 IQGAP1 GRIP1 PARP4 LRPPRC DST KRT6C MICAL2 RP1L1 PDE4DIP DIAPH2 EML1 TUBE1 KRT37 | 3.29e-10 | 899 | 152 | 27 | GO:0099513 |
| GeneOntologyCellularComponent | cell cortex | FLNA IQGAP2 TCHP PCLO PPFIA3 AQP7 IQGAP1 GRIP1 FRY DST PDE4DIP ERC2 FGFR2 | 3.34e-06 | 371 | 152 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 3.68e-06 | 263 | 152 | 11 | GO:0045111 | |
| GeneOntologyCellularComponent | intermediate filament | 6.54e-06 | 227 | 152 | 10 | GO:0005882 | |
| GeneOntologyCellularComponent | microtubule | SPAST KIF27 IQGAP2 RIBC1 FSD1 DNAH7 IQGAP1 GRIP1 PARP4 LRPPRC DST RP1L1 PDE4DIP EML1 TUBE1 | 8.33e-06 | 533 | 152 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | myofibril | 3.22e-05 | 273 | 152 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | desmosome | 4.80e-05 | 28 | 152 | 4 | GO:0030057 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.37e-05 | 290 | 152 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | cytoplasmic region | SPAST TCHP CENPF PCLO RIBC1 PPFIA3 DNAH7 DST RP1L1 PRKAR2A ERC2 | 6.75e-05 | 360 | 152 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | keratin filament | 7.67e-05 | 97 | 152 | 6 | GO:0045095 | |
| GeneOntologyCellularComponent | centrosome | SPAST TCHP CENPF ALS2 FSD1 BIRC6 RABL6 ODF2L FRY TRIM69 GLE1 PDE4DIP PRKAR2A CROCC TUBE1 CEP97 | 1.59e-04 | 770 | 152 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | cell cortex region | 3.17e-04 | 45 | 152 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | microtubule organizing center | SPAST TCHP CENPF MYO18A ALS2 FSD1 BIRC6 RABL6 ODF2L FRY TRIM69 GLE1 PDE4DIP PRKAR2A CROCC TUBE1 CEP97 | 3.85e-04 | 919 | 152 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 6.00e-04 | 23 | 152 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | myosin filament | 7.71e-04 | 25 | 152 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | meiotic cohesin complex | 1.08e-03 | 7 | 152 | 2 | GO:0030893 | |
| GeneOntologyCellularComponent | myosin II complex | 1.08e-03 | 28 | 152 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.43e-03 | 8 | 152 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | cornified envelope | 1.61e-03 | 69 | 152 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 2.27e-03 | 10 | 152 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | sarcomere | 2.34e-03 | 249 | 152 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.54e-03 | 129 | 152 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | cohesin complex | 2.77e-03 | 11 | 152 | 2 | GO:0008278 | |
| HumanPheno | Gastrostomy tube feeding in infancy | 1.73e-06 | 104 | 57 | 9 | HP:0011471 | |
| HumanPheno | Natal tooth | 3.14e-06 | 38 | 57 | 6 | HP:0000695 | |
| HumanPheno | Abnormal blistering of the skin | 4.04e-06 | 115 | 57 | 9 | HP:0008066 | |
| HumanPheno | Palmoplantar blistering | 4.39e-06 | 11 | 57 | 4 | HP:0007446 | |
| HumanPheno | Nail dystrophy | 6.80e-06 | 156 | 57 | 10 | HP:0008404 | |
| HumanPheno | Blistering by anatomical location | 8.07e-06 | 26 | 57 | 5 | HP:0033800 | |
| HumanPheno | Advanced eruption of teeth | 9.95e-06 | 46 | 57 | 6 | HP:0006288 | |
| HumanPheno | Feeding difficulties in infancy | FLNA KRT5 FAT4 ATP6V0A1 DEAF1 ATRX TRIO SYNE1 SPTLC1 KDM3B ALS2 CHD8 REV3L PNPT1 LRPPRC DST RTL1 ARHGAP29 FGFR2 | 1.22e-05 | 594 | 57 | 19 | HP:0008872 |
| HumanPheno | Supernumerary tooth | 3.78e-05 | 85 | 57 | 7 | HP:0011069 | |
| HumanPheno | Abnormal oral mucosa morphology | IL12A KRT4 KRT5 KRT6A KRT6B FAT4 EVC2 ATRX DSG3 DSP SREBF1 STAT4 KRT6C FGFR2 | 5.30e-05 | 381 | 57 | 14 | HP:0011830 |
| HumanPheno | Abnormality of dental eruption | FLNA KRT6A KRT6B FAT4 EVC2 DEAF1 TRIO DSP TRIP11 ARHGAP29 FGFR2 | 5.43e-05 | 240 | 57 | 11 | HP:0006292 |
| HumanPheno | Palmoplantar hyperkeratosis | 7.92e-05 | 129 | 57 | 8 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 8.84e-05 | 131 | 57 | 8 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 9.33e-05 | 132 | 57 | 8 | HP:0007556 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the thumb | 1.42e-04 | 46 | 57 | 5 | HP:0009658 | |
| HumanPheno | Feeding difficulties | FLNA KRT5 FAT4 ATP6V0A1 DEAF1 ATRX TRIO PYROXD1 SYNE1 SPTLC1 NR4A2 KDM3B ALS2 CHD8 REV3L PNPT1 LRPPRC DST RTL1 GLE1 ARHGAP29 PYGM FGFR2 | 1.79e-04 | 982 | 57 | 23 | HP:0002022 |
| HumanPheno | Hyperkeratosis | 2.14e-04 | 233 | 57 | 10 | HP:0000962 | |
| HumanPheno | White lesion of the oral mucosa | 2.36e-04 | 28 | 57 | 4 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 2.36e-04 | 28 | 57 | 4 | HP:0002745 | |
| HumanPheno | Palmoplantar keratoderma | 2.45e-04 | 114 | 57 | 7 | HP:0000982 | |
| HumanPheno | Angular cheilitis | 2.72e-04 | 12 | 57 | 3 | HP:0030318 | |
| HumanPheno | Abnormality of keratinization | 3.12e-04 | 244 | 57 | 10 | HP:0001035 | |
| MousePheno | abnormal tongue epithelium morphology | 4.41e-06 | 27 | 130 | 5 | MP:0000764 | |
| MousePheno | abnormal oral mucosa morphology | 6.65e-06 | 14 | 130 | 4 | MP:0003745 | |
| MousePheno | oral mucosa blisters | 8.58e-05 | 2 | 130 | 2 | MP:0030520 | |
| MousePheno | abnormal head morphology | KRT4 FLNA KRT5 KRT6A KRT6B EVC2 ATP6V0A1 KIF27 TCHP DSG3 DSP KDM3B LAMA5 NBEA CHD8 TRIP11 MAP3K3 DST PSIP1 ARHGAP29 FGFR2 EML1 CEP97 TP53BP2 | 9.11e-05 | 1120 | 130 | 24 | MP:0000432 |
| MousePheno | abnormal facial morphology | KRT4 FLNA KRT5 KRT6A KRT6B EVC2 ATP6V0A1 KIF27 TCHP DSG3 DSP KDM3B LAMA5 NBEA TRIP11 DST PSIP1 ARHGAP29 FGFR2 CEP97 TP53BP2 | 9.56e-05 | 910 | 130 | 21 | MP:0003743 |
| MousePheno | abnormal synaptic vesicle morphology | 1.07e-04 | 51 | 130 | 5 | MP:0004769 | |
| MousePheno | abnormal tongue morphology | 1.15e-04 | 118 | 130 | 7 | MP:0000762 | |
| MousePheno | abnormal craniofacial morphology | FOXO1 KRT4 FLNA KRT5 KRT6A KRT6B EVC2 ATP6V0A1 KIF27 TCHP DSG3 DSP KDM3B LAMA5 NBEA CACHD1 REV3L TRIP11 ADCY9 DST FAF2 PSIP1 ARHGAP29 FGFR2 EML1 CEP97 TP53BP2 | 1.31e-04 | 1372 | 130 | 27 | MP:0000428 |
| MousePheno | craniofacial phenotype | FOXO1 KRT4 FLNA KRT5 KRT6A KRT6B EVC2 ATP6V0A1 KIF27 TCHP DSG3 DSP KDM3B LAMA5 NBEA CACHD1 REV3L TRIP11 ADCY9 DST FAF2 PSIP1 ARHGAP29 FGFR2 EML1 CEP97 TP53BP2 | 1.31e-04 | 1372 | 130 | 27 | MP:0005382 |
| MousePheno | abnormal mouth morphology | KRT4 FLNA KRT5 KRT6A KRT6B EVC2 ATP6V0A1 TCHP DSG3 DSP LAMA5 NBEA DST ARHGAP29 FGFR2 CEP97 TP53BP2 | 1.56e-04 | 670 | 130 | 17 | MP:0000452 |
| Domain | Intermediate_filament_CS | 7.78e-07 | 63 | 152 | 7 | IPR018039 | |
| Domain | Keratin_II | 1.92e-06 | 26 | 152 | 5 | IPR003054 | |
| Domain | IF | 1.95e-06 | 72 | 152 | 7 | PS00226 | |
| Domain | Filament | 2.14e-06 | 73 | 152 | 7 | PF00038 | |
| Domain | IF | 2.81e-06 | 76 | 152 | 7 | IPR001664 | |
| Domain | Spectrin_repeat | 3.39e-06 | 29 | 152 | 5 | IPR002017 | |
| Domain | SPEC | 5.64e-06 | 32 | 152 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.64e-06 | 32 | 152 | 5 | IPR018159 | |
| Domain | IQ | 1.09e-05 | 93 | 152 | 7 | PS50096 | |
| Domain | CH | 1.46e-05 | 65 | 152 | 6 | SM00033 | |
| Domain | Myosin-like_IQ_dom | 1.49e-05 | 19 | 152 | 4 | IPR027401 | |
| Domain | - | 1.49e-05 | 19 | 152 | 4 | 4.10.270.10 | |
| Domain | CH | 2.25e-05 | 70 | 152 | 6 | PF00307 | |
| Domain | IQ | 2.44e-05 | 71 | 152 | 6 | PF00612 | |
| Domain | Filament | 2.44e-05 | 71 | 152 | 6 | SM01391 | |
| Domain | - | 2.44e-05 | 71 | 152 | 6 | 1.10.418.10 | |
| Domain | CH | 2.86e-05 | 73 | 152 | 6 | PS50021 | |
| Domain | Spectrin | 3.31e-05 | 23 | 152 | 4 | PF00435 | |
| Domain | CH-domain | 3.34e-05 | 75 | 152 | 6 | IPR001715 | |
| Domain | Keratin_2_head | 3.95e-05 | 24 | 152 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 3.95e-05 | 24 | 152 | 4 | PF16208 | |
| Domain | IQ | 5.17e-05 | 81 | 152 | 6 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 9.33e-05 | 90 | 152 | 6 | IPR000048 | |
| Domain | RasGAP_C | 1.96e-04 | 3 | 152 | 2 | IPR000593 | |
| Domain | RFX1_trans_act | 1.96e-04 | 3 | 152 | 2 | IPR007668 | |
| Domain | RFX1_trans_act | 1.96e-04 | 3 | 152 | 2 | PF04589 | |
| Domain | RasGAP_C | 1.96e-04 | 3 | 152 | 2 | PF03836 | |
| Domain | Prefoldin | 3.02e-04 | 72 | 152 | 5 | IPR009053 | |
| Domain | Desmoglein | 3.91e-04 | 4 | 152 | 2 | IPR009123 | |
| Domain | Myosin_tail_1 | 3.94e-04 | 18 | 152 | 3 | PF01576 | |
| Domain | Myosin_tail | 3.94e-04 | 18 | 152 | 3 | IPR002928 | |
| Domain | Rho_GTPase_activation_prot | 7.61e-04 | 88 | 152 | 5 | IPR008936 | |
| Domain | ACTININ_2 | 8.30e-04 | 23 | 152 | 3 | PS00020 | |
| Domain | ACTININ_1 | 8.30e-04 | 23 | 152 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.30e-04 | 23 | 152 | 3 | IPR001589 | |
| Domain | tRNA-bd_arm | 9.43e-04 | 24 | 152 | 3 | IPR010978 | |
| Domain | - | 9.66e-04 | 6 | 152 | 2 | 3.90.1290.10 | |
| Domain | Desmosomal_cadherin | 1.35e-03 | 7 | 152 | 2 | IPR009122 | |
| Domain | Plectin | 1.35e-03 | 7 | 152 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.35e-03 | 7 | 152 | 2 | IPR001101 | |
| Domain | PLEC | 1.35e-03 | 7 | 152 | 2 | SM00250 | |
| Domain | VIT | 1.78e-03 | 8 | 152 | 2 | PF08487 | |
| Domain | VIT | 1.78e-03 | 8 | 152 | 2 | SM00609 | |
| Domain | UBA-like | 1.83e-03 | 64 | 152 | 4 | IPR009060 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.22e-07 | 129 | 118 | 10 | M27649 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 6.39e-07 | 87 | 118 | 8 | MM15351 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TRIO IQGAP2 DSG1 TAGAP DSP DOCK8 FRS3 ARHGAP17 ALS2 IQGAP1 DST FAF2 DIAPH2 ARHGAP29 CEP97 | 3.80e-06 | 439 | 118 | 15 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TRIO IQGAP2 DSG1 TAGAP DSP DOCK8 FRS3 ARHGAP17 ALS2 IQGAP1 DST FAF2 DIAPH2 ARHGAP29 CEP97 | 5.13e-06 | 450 | 118 | 15 | M27078 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | FLNA TRIO IQGAP2 DSG1 CENPF TAGAP DSP DOCK8 FRS3 ARHGAP17 ALS2 IQGAP1 DST FAF2 DIAPH2 NUP133 ARHGAP29 CEP97 | 7.16e-06 | 649 | 118 | 18 | MM15690 |
| Pathway | REACTOME_KERATINIZATION | 1.39e-05 | 217 | 118 | 10 | M27640 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | FLNA TRIO IQGAP2 DSG1 CENPF TAGAP DSP DOCK8 FRS3 ARHGAP17 ALS2 IQGAP1 DST FAF2 DIAPH2 NUP133 ARHGAP29 CEP97 | 2.90e-05 | 720 | 118 | 18 | M41838 |
| Pathway | REACTOME_KERATINIZATION | 4.28e-05 | 153 | 118 | 8 | MM15343 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 6.57e-05 | 10 | 118 | 3 | MM14956 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | 8.98e-05 | 11 | 118 | 3 | M9990 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.10e-04 | 175 | 118 | 8 | MM15599 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.56e-04 | 184 | 118 | 8 | M41809 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 3.23e-04 | 155 | 118 | 7 | M41808 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO1 MTMR12 SPAST TRIO DSP RIPK2 KDM3B MPDZ ARHGAP17 CRTC1 ALS2 FSD1 MAP3K6 TRIP12 TRIP11 DNAH7 MAP3K3 GRIP1 FAM171A1 LRPPRC DST N4BP2 CCSER2 TP53BP2 | 8.74e-13 | 861 | 155 | 24 | 36931259 |
| Pubmed | TRIO IQGAP2 CENPF SYNE1 KSR2 RIPK2 MPDZ NBEA CHD8 PPFIA3 TRIP11 STRIP1 IQGAP1 FAM171A1 LRPPRC FRY DST N4BP2 PDE4DIP DIAPH2 PRKAR2A ERC2 EML1 TP53BP2 | 9.11e-12 | 963 | 155 | 24 | 28671696 | |
| Pubmed | FLNA KRT5 KRT6A KRT6B ATP6V0A1 TRIO IQGAP2 DSP DOCK8 SYNE1 PCLO MYO18A PSMD2 NBEA PPFIA3 TRIP11 STRIP1 IQGAP1 LRPPRC DST MICAL2 PDE4DIP PRKAR2A ERC2 CORO6 CROCC TP53BP2 | 2.17e-10 | 1431 | 155 | 27 | 37142655 | |
| Pubmed | ATP6V0A1 SPAST ATRX TRIO DSP SYNE1 NR4A2 PSMD2 NBEA CACHD1 REV3L TRIP12 TRIP11 IQGAP1 CUEDC1 STAB1 MIPOL1 ODF2L FRY DST MICAL2 PDE4DIP ERC2 CD74 QTRT1 | 5.91e-10 | 1285 | 155 | 25 | 35914814 | |
| Pubmed | FLNA KRT5 KRT6A KRT6B KRT12 MYH13 ATRX IQGAP2 CENPF DSP PYROXD1 SYNE1 PCLO MYO18A PSMD2 TRIP12 IQGAP1 MIPOL1 LRPPRC DST PSIP1 KRT6C RRP36 N4BP2 ERC2 MYH15 | 1.27e-09 | 1442 | 155 | 26 | 35575683 | |
| Pubmed | FLNA KRT5 KRT6A KRT6B KRT12 DSG1 DSP SPTLC1 MYO18A LAMA5 PSMD2 IQGAP1 FAF2 KRT6C PRKAR2A | 5.88e-09 | 488 | 155 | 15 | 31324722 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 CCDC73 CENPF DSP PCLO PBX4 LRRC40 NBEA REV3L PPFIA3 TRIP12 BIRC6 MIPOL1 PARP4 FRY DST PSIP1 TUBE1 | 5.91e-09 | 736 | 155 | 18 | 29676528 |
| Pubmed | SYNE1 KDM3B ALS2 CHD8 PPFIA3 BIRC6 ADCY9 STAB1 SULF2 DST ERC2 | 6.22e-09 | 225 | 155 | 11 | 12168954 | |
| Pubmed | KRT5 FAT4 MYH13 IQGAP2 MAML1 KDM3B NBEA TRIP12 BIRC6 TRIP11 DNAH7 ADCY9 STRIP1 RABL6 DST FAF2 GCC2 RHBDD3 | 1.36e-08 | 777 | 155 | 18 | 35844135 | |
| Pubmed | 1.37e-08 | 63 | 155 | 7 | 16831889 | ||
| Pubmed | 2.91e-08 | 107 | 155 | 8 | 32989256 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 29357356 | ||
| Pubmed | Making a connection: direct binding between keratin intermediate filaments and desmosomal proteins. | 8.68e-08 | 3 | 155 | 3 | 7525601 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 29587848 | ||
| Pubmed | FoxO1 represses LXRα-mediated transcriptional activity of SREBP-1c promoter in HepG2 cells. | 8.68e-08 | 3 | 155 | 3 | 20868688 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7543104 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA TBC1D9B TRIO KSR2 SREBF1 MAML1 KDM3B IPP LAMA5 ARHGAP17 CHD8 REV3L BIRC6 ADCY9 PCNX2 RABL6 DST MROH1 DIAPH2 FGFR2 | 1.17e-07 | 1105 | 155 | 20 | 35748872 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA KRT5 KRT6A CHERP DSG1 CENPF DSP SYNE1 PSMD2 LRRC40 TRIP12 IQGAP1 LRPPRC DST PSIP1 KRT6C RRP36 GLE1 NUP133 | 1.71e-07 | 1024 | 155 | 19 | 24711643 |
| Pubmed | FLNA KRT5 DSG1 DSP MYO18A PSMD2 IQGAP1 LRPPRC FAF2 KRT6C GCC2 | 1.75e-07 | 312 | 155 | 11 | 37120454 | |
| Pubmed | 2.12e-07 | 191 | 155 | 9 | 33762435 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KRT5 TRIO DSP RIBC1 MAML1 PPP1R13B CRTC1 DNAH7 IQGAP1 MIPOL1 GRIP1 ODF2L EIF2D N4BP2 ARHGAP29 CEP97 TP53BP2 | 2.97e-07 | 853 | 155 | 17 | 28718761 |
| Pubmed | FLNA KRT5 DSP SYNE1 MYO18A PPP1R13B ARHGAP17 CRTC1 CHD8 MAP3K3 DST N4BP2 DIAPH2 | 3.12e-07 | 486 | 155 | 13 | 20936779 | |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 30389720 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CHERP KIF27 ATRX DSP DOCK8 PSMD2 LRRC40 CHD8 INTS3 TRIP12 IQGAP1 STAB1 PARP4 EIF2D | 3.86e-07 | 582 | 155 | 14 | 20467437 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | FLNA SPAST IQGAP2 CENPF PCLO NBEA TRIP12 STRIP1 GRIP1 DST FAF2 PSIP1 PRKAR2A | 4.10e-07 | 498 | 155 | 13 | 36634849 |
| Pubmed | 4.20e-07 | 151 | 155 | 8 | 17043677 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF597 FLNA CHERP DSG1 DSP MED16 CYP20A1 SPTLC1 SREBF1 PSMD2 CHD8 INTS3 STRIP1 GZF1 FAF2 PSIP1 MICAL2 GLE1 CCSER2 ERC2 | 4.49e-07 | 1203 | 155 | 20 | 29180619 |
| Pubmed | FLNA EVC2 ATRX DOCK8 KDM3B LAMA5 PPP1R13B TRIP12 CUEDC1 GRIP1 TRIM69 DST PDE4DIP TP53BP2 | 4.64e-07 | 591 | 155 | 14 | 15231748 | |
| Pubmed | Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. | 4.99e-07 | 15 | 155 | 4 | 9847250 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 5.10e-07 | 212 | 155 | 9 | 33853758 | |
| Pubmed | 6.52e-07 | 284 | 155 | 10 | 29459677 | ||
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 6.62e-07 | 16 | 155 | 4 | 12399393 | |
| Pubmed | SPAST MAML1 KDM3B LAMA5 CRTC1 CHD8 CACHD1 ADCY9 IQGAP1 STAB1 SULF2 DST CCSER2 | 8.07e-07 | 529 | 155 | 13 | 14621295 | |
| Pubmed | MTMR12 TCHP DOCK8 PPP1R13B MPDZ BIRC6 STRIP1 MIPOL1 GRIP1 DST CCSER2 TP53BP2 | 8.49e-07 | 446 | 155 | 12 | 24255178 | |
| Pubmed | Role for keratins 6 and 17 during wound closure in embryonic mouse skin. | 8.63e-07 | 5 | 155 | 3 | 12557214 | |
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 23075894 | ||
| Pubmed | Airway hillocks are injury-resistant reservoirs of unique plastic stem cells. | 8.63e-07 | 5 | 155 | 3 | 38693267 | |
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 18202130 | ||
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 20301457 | ||
| Pubmed | Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. | 8.63e-07 | 5 | 155 | 3 | 1713141 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | FLNA TBC1D9B ATP6V0A1 SPTLC1 PSMD2 LRRC40 CACHD1 TRIP12 DIPK2A IQGAP1 LRPPRC FAF2 GLE1 NUP133 PRKAR2A RHBDD3 CEP97 | 1.16e-06 | 942 | 155 | 17 | 31073040 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.19e-06 | 120 | 155 | 7 | 31413325 | |
| Pubmed | FLNA FAT4 CHERP DSP SYNE1 SPTLC1 SREBF1 MYO18A LAMA5 PSMD2 PPFIA3 TRIP11 PNPT1 EML1 TMCO3 | 1.57e-06 | 754 | 155 | 15 | 35906200 | |
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 16239341 | ||
| Pubmed | Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins. | 1.72e-06 | 6 | 155 | 3 | 23088536 | |
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 16790075 | ||
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 17050673 | ||
| Pubmed | p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. | 1.72e-06 | 6 | 155 | 3 | 25383540 | |
| Pubmed | Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice. | 1.74e-06 | 45 | 155 | 5 | 28973166 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 1.81e-06 | 247 | 155 | 9 | 39238192 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 2.17e-06 | 84 | 155 | 6 | 29563501 | |
| Pubmed | MTMR12 SYNE1 ALS2 STRIP1 FAF2 MROH1 GCC2 PDE4DIP BRINP2 ERC2 CROCC | 2.36e-06 | 407 | 155 | 11 | 12693553 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | FOXO1 KRT5 ATRX TCHP DSP MAML1 PPP1R13B ARHGAP17 E2F2 TRIP11 ODF2L N4BP2 ERC2 | 2.59e-06 | 588 | 155 | 13 | 38580884 |
| Pubmed | TRIO DSP SYNE1 BIRC6 TRIP11 PRKD3 PARP4 LRPPRC DST PDE4DIP NUP133 PYGM | 2.60e-06 | 497 | 155 | 12 | 23414517 | |
| Pubmed | 3.00e-06 | 7 | 155 | 3 | 19720911 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATP6V0A1 MYH13 ATRX TRIO MED16 RIPK2 MAP3K6 MAP3K3 PRKD3 DST RTL1 PDE4DIP NUP133 PRKAR2A MYH15 FGFR2 | 3.41e-06 | 910 | 155 | 16 | 36736316 |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 3.47e-06 | 91 | 155 | 6 | 34445801 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.74e-06 | 202 | 155 | 8 | 33005030 | |
| Pubmed | 4.78e-06 | 8 | 155 | 3 | 15706352 | ||
| Pubmed | Identification of trichoplein, a novel keratin filament-binding protein. | 4.78e-06 | 8 | 155 | 3 | 15731013 | |
| Pubmed | FLNA KRT5 KRT6A CHERP MED16 DOCK8 CYP20A1 MYO18A PSMD2 LRRC40 BIRC6 PARP4 LRPPRC GLE1 GCC2 NUP133 PRKAR2A CD74 | 5.06e-06 | 1168 | 155 | 18 | 19946888 | |
| Pubmed | Epidermal development requires ninein for spindle orientation and cortical microtubule organization. | 5.26e-06 | 26 | 155 | 4 | 30923192 | |
| Pubmed | 5.72e-06 | 57 | 155 | 5 | 31862882 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA ATP6V0A1 CHERP KIF27 ATRX TRIO DSG1 CENPF DSP SYNE1 PCLO SPTLC1 PSMD2 LRRC40 IQGAP1 LRPPRC FAF2 PSIP1 NUP133 PRKAR2A | 5.88e-06 | 1425 | 155 | 20 | 30948266 |
| Pubmed | FAT4 DRP2 MAML1 KDM3B NBEA REV3L PPFIA3 INTS3 TRIP11 DNAH7 PARP4 FAF2 GCC2 | 6.24e-06 | 638 | 155 | 13 | 31182584 | |
| Pubmed | 6.32e-06 | 288 | 155 | 9 | 23383273 | ||
| Pubmed | Type II keratins precede type I keratins during early embryonic development. | 7.15e-06 | 9 | 155 | 3 | 16180309 | |
| Pubmed | 7.39e-06 | 60 | 155 | 5 | 31220272 | ||
| Pubmed | MTMR12 ATRX SREBF1 KDM3B MPDZ CHD8 INTS3 MAP3K6 PARP4 EIF2D SULF2 DST DIAPH2 | 7.62e-06 | 650 | 155 | 13 | 38777146 | |
| Pubmed | FLNA CHERP CENPF DSP PSMD2 CHD8 TRIP12 BIRC6 IQGAP1 PNPT1 LRPPRC DST NUP133 | 8.00e-06 | 653 | 155 | 13 | 22586326 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | KRT4 FLNA KRT5 KRT6A KRT6B KRT12 CHERP MYH13 DSG1 DSP PSMD2 PDE4DIP | 8.40e-06 | 558 | 155 | 12 | 27591049 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FLNA TBC1D9B DEAF1 ATRX FRS3 LAMA5 STAB1 MIPOL1 GRIP1 NUP133 CORO6 EML1 | 8.71e-06 | 560 | 155 | 12 | 21653829 |
| Pubmed | 9.50e-06 | 30 | 155 | 4 | 34905516 | ||
| Pubmed | 1.02e-05 | 10 | 155 | 3 | 12724416 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT4 FLNA KRT5 KRT6A KRT6B DSG1 DSG3 CENPF DSP MYO18A PSMD2 TRIP12 ITIH2 IQGAP1 LRPPRC DST PSIP1 NUP133 | 1.37e-05 | 1257 | 155 | 18 | 36526897 |
| Pubmed | 1.40e-05 | 11 | 155 | 3 | 11790773 | ||
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 1.40e-05 | 11 | 155 | 3 | 8707838 | |
| Pubmed | 1.40e-05 | 11 | 155 | 3 | 18218630 | ||
| Pubmed | Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis. | 1.40e-05 | 11 | 155 | 3 | 21844209 | |
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 1.40e-05 | 11 | 155 | 3 | 20351715 | |
| Pubmed | 1.40e-05 | 11 | 155 | 3 | 12802069 | ||
| Pubmed | 1.82e-05 | 251 | 155 | 8 | 29778605 | ||
| Pubmed | Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. | 1.85e-05 | 12 | 155 | 3 | 14610062 | |
| Pubmed | 1.85e-05 | 12 | 155 | 3 | 12707304 | ||
| Pubmed | DSP MPDZ PSMD2 LRRC40 CACHD1 ADCY9 IQGAP1 GRIP1 RABL6 FAM171A1 LRPPRC DST ARHGAP29 | 1.87e-05 | 708 | 155 | 13 | 39231216 | |
| Pubmed | 1.97e-05 | 418 | 155 | 10 | 34709266 | ||
| Pubmed | Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha. | 1.97e-05 | 2 | 155 | 2 | 16054077 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 28620161 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 10550543 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 10550545 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15731015 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 15757645 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 33766895 | ||
| Pubmed | Differential effects of desmoglein 1 and desmoglein 3 on desmosome formation. | 1.97e-05 | 2 | 155 | 2 | 12485422 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 9790766 | ||
| Pubmed | Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. | 1.97e-05 | 2 | 155 | 2 | 8700208 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 18514749 | ||
| Pubmed | [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers]. | 1.97e-05 | 2 | 155 | 2 | 22169642 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11489919 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 22311022 | ||
| Interaction | DSCR9 interactions | 1.96e-07 | 147 | 154 | 10 | int:DSCR9 | |
| Interaction | YWHAH interactions | FOXO1 MTMR12 EVC2 SPAST TRIO DSP KSR2 RIPK2 KDM3B MPDZ ARHGAP17 PSMD2 CRTC1 ALS2 FSD1 MAP3K6 TRIP12 TRIP11 DNAH7 MAP3K3 IQGAP1 GRIP1 FAM171A1 DST CCSER2 TP53BP2 | 2.69e-07 | 1102 | 154 | 26 | int:YWHAH |
| Interaction | KRT19 interactions | KRT4 KRT5 KRT6A KRT6B KRT12 TCHP DSP PPP1R13B BIRC6 ODF2L KRT6C GCC2 TP53BP2 | 2.70e-07 | 282 | 154 | 13 | int:KRT19 |
| Interaction | KRT18 interactions | KRT4 KRT5 KRT6A KRT6B KRT12 TCHP DSP PPP1R13B BIRC6 ODF2L FAF2 KRT6C N4BP2 PDE4DIP CEP97 | 8.08e-07 | 419 | 154 | 15 | int:KRT18 |
| Interaction | YWHAG interactions | FOXO1 FLNA MTMR12 SPAST DSP KSR2 RIPK2 KDM3B MPDZ ARHGAP17 CRTC1 ALS2 MAP3K6 TRIP12 TRIP11 DNAH7 MAP3K3 IQGAP1 GRIP1 FAM171A1 DST N4BP2 GCC2 CCSER2 ARHGAP29 CEP97 TP53BP2 | 8.41e-07 | 1248 | 154 | 27 | int:YWHAG |
| Interaction | KRT8 interactions | KRT5 KRT6A KRT6B KRT12 TCHP DSP PPP1R13B BIRC6 TRIP11 FAF2 KRT6C N4BP2 CCSER2 CEP97 KRT37 | 1.53e-06 | 441 | 154 | 15 | int:KRT8 |
| Interaction | KRT35 interactions | 2.20e-06 | 111 | 154 | 8 | int:KRT35 | |
| Interaction | KRT28 interactions | 2.98e-06 | 30 | 154 | 5 | int:KRT28 | |
| Interaction | PPARGC1A interactions | 3.12e-06 | 82 | 154 | 7 | int:PPARGC1A | |
| Interaction | PARD3 interactions | MTMR12 TRIO TCHP SPTLC1 PPP1R13B MPDZ ARHGAP17 FAM171A1 DST CCSER2 ARHGAP29 TP53BP2 | 3.24e-06 | 298 | 154 | 12 | int:PARD3 |
| Interaction | PRPH interactions | KRT5 KRT6A KRT6B KRT12 TCHP DSP RIPK2 PPP1R13B KRT6C TP53BP2 | 3.92e-06 | 204 | 154 | 10 | int:PRPH |
| Interaction | RNF123 interactions | FAT4 CCDC73 CENPF DSP PCLO PBX4 LRRC40 NBEA REV3L PPFIA3 MAP3K6 TRIP12 BIRC6 DIPK2A MIPOL1 PARP4 FRY DST PSIP1 TUBE1 | 4.92e-06 | 824 | 154 | 20 | int:RNF123 |
| Interaction | KRT25 interactions | 6.59e-06 | 35 | 154 | 5 | int:KRT25 | |
| Interaction | LATS1 interactions | KRT4 KRT5 KRT6A CHERP MYH13 DSG1 TCHP PPP1R13B MPDZ TRIP11 MAP3K3 KRT6C PYGM TP53BP2 | 7.44e-06 | 440 | 154 | 14 | int:LATS1 |
| Interaction | GOLGA1 interactions | 1.18e-05 | 183 | 154 | 9 | int:GOLGA1 | |
| Interaction | PHTF1 interactions | 1.44e-05 | 20 | 154 | 4 | int:PHTF1 | |
| Interaction | KRT5 interactions | 1.80e-05 | 193 | 154 | 9 | int:KRT5 | |
| Interaction | KCTD13 interactions | FLNA KRT5 KRT6A ATP6V0A1 TRIO IQGAP2 DSP DOCK8 SYNE1 PCLO MYO18A PSMD2 NBEA PPFIA3 TRIP11 STRIP1 IQGAP1 LRPPRC DST MICAL2 PRKAR2A ERC2 CORO6 CROCC CEP97 TP53BP2 | 1.98e-05 | 1394 | 154 | 26 | int:KCTD13 |
| Interaction | KRT36 interactions | 2.18e-05 | 74 | 154 | 6 | int:KRT36 | |
| Interaction | KRT12 interactions | 3.09e-05 | 24 | 154 | 4 | int:KRT12 | |
| Interaction | FGD5 interactions | 3.13e-05 | 207 | 154 | 9 | int:FGD5 | |
| Interaction | KRT6A interactions | 3.24e-05 | 160 | 154 | 8 | int:KRT6A | |
| Interaction | KRT84 interactions | 3.55e-05 | 49 | 154 | 5 | int:KRT84 | |
| Interaction | H2BC9 interactions | ATRX DSG1 DSP ABCA13 PCLO PARP4 SULF2 DST FAF2 PSIP1 PDE4DIP CROCC TP53BP2 | 3.97e-05 | 446 | 154 | 13 | int:H2BC9 |
| Interaction | KRT38 interactions | 5.42e-05 | 172 | 154 | 8 | int:KRT38 | |
| Interaction | TIMP2 interactions | 5.52e-05 | 277 | 154 | 10 | int:TIMP2 | |
| Interaction | KRT24 interactions | 5.71e-05 | 54 | 154 | 5 | int:KRT24 | |
| Interaction | PPP1R13B interactions | 6.37e-05 | 176 | 154 | 8 | int:PPP1R13B | |
| Interaction | PEX14 interactions | 8.92e-05 | 237 | 154 | 9 | int:PEX14 | |
| Interaction | WWOX interactions | KRT4 ATRX IQGAP2 TCHP DSG3 DSP SPTLC1 MYO18A FRS3 KDM3B MPDZ PBX4 TRIM69 FAF2 NUP133 | 9.53e-05 | 627 | 154 | 15 | int:WWOX |
| Interaction | CDC5L interactions | CHERP TRIO DSP DOCK8 SYNE1 PPP1R13B PSMD2 LRRC40 CHD8 INTS3 IQGAP1 STAB1 PARP4 EIF2D DST GLE1 PDE4DIP TP53BP2 | 9.64e-05 | 855 | 154 | 18 | int:CDC5L |
| Interaction | KRT14 interactions | 1.17e-04 | 192 | 154 | 8 | int:KRT14 | |
| Interaction | KRT20 interactions | 1.20e-04 | 63 | 154 | 5 | int:KRT20 | |
| Interaction | SNCA interactions | FLNA SPAST IQGAP2 CENPF DSP PCLO NBEA FSD1 TRIP12 STRIP1 GRIP1 DST FAF2 PSIP1 PDE4DIP PRKAR2A | 1.22e-04 | 716 | 154 | 16 | int:SNCA |
| Interaction | CRK interactions | KRT4 FLNA KRT5 KRT6A KRT6B KRT12 MPDZ ARHGAP17 STAT4 CORO6 TP53BP2 | 1.33e-04 | 370 | 154 | 11 | int:CRK |
| Interaction | KRT16 interactions | 1.40e-04 | 197 | 154 | 8 | int:KRT16 | |
| Interaction | KRT17 interactions | 1.42e-04 | 252 | 154 | 9 | int:KRT17 | |
| Interaction | KRT26 interactions | 1.43e-04 | 35 | 154 | 4 | int:KRT26 | |
| Interaction | AMOT interactions | FLNA TCHP PPP1R13B MPDZ ARHGAP17 BIRC6 N4BP2 CCSER2 CEP97 TP53BP2 | 1.47e-04 | 312 | 154 | 10 | int:AMOT |
| Interaction | PFN1 interactions | TRIO DOCK8 PCLO ARHGAP17 NBEA BIRC6 TRIP11 N4BP2 GCC2 DIAPH2 ARHGAP29 PRKAR2A CEP97 | 1.50e-04 | 509 | 154 | 13 | int:PFN1 |
| Interaction | ZBTB4 interactions | 1.60e-04 | 36 | 154 | 4 | int:ZBTB4 | |
| Interaction | NBR1 interactions | FLNA DSP RIPK2 PSMD2 E2F2 MAP3K3 LRPPRC DST PSIP1 RRP36 CORO6 | 1.68e-04 | 380 | 154 | 11 | int:NBR1 |
| Interaction | TNIK interactions | TRIO CENPF SYNE1 PPP1R13B NBEA CHD8 STRIP1 DST PDE4DIP PRKAR2A ERC2 | 1.72e-04 | 381 | 154 | 11 | int:TNIK |
| Interaction | CDC42 interactions | FLNA FAT4 ATP6V0A1 TRIO IQGAP2 DSG1 DSP DOCK8 SYNE1 KSR2 SPTLC1 MYO18A PPP1R13B ARHGAP17 TRIP11 ADCY9 IQGAP1 RABL6 FAM171A1 FAF2 PSIP1 DIAPH2 ARHGAP29 | 1.81e-04 | 1323 | 154 | 23 | int:CDC42 |
| Interaction | EFNA3 interactions | 1.82e-04 | 108 | 154 | 6 | int:EFNA3 | |
| Interaction | LRRC31 interactions | 1.83e-04 | 205 | 154 | 8 | int:LRRC31 | |
| Interaction | OBSL1 interactions | FLNA KRT5 KRT6A KRT6B CHERP CENPF DSP SYNE1 PCLO LAMA5 PSMD2 TRIP12 IQGAP1 DST PSIP1 RRP36 NUP133 ERC2 | 1.88e-04 | 902 | 154 | 18 | int:OBSL1 |
| Interaction | DES interactions | 2.16e-04 | 158 | 154 | 7 | int:DES | |
| Interaction | AGAP2 interactions | 2.16e-04 | 210 | 154 | 8 | int:AGAP2 | |
| Interaction | AFDN interactions | SPAST TCHP PPP1R13B TRIP11 ADCY9 FAM171A1 DST GCC2 ARHGAP29 TP53BP2 | 2.49e-04 | 333 | 154 | 10 | int:AFDN |
| Interaction | RNF208 interactions | 2.74e-04 | 75 | 154 | 5 | int:RNF208 | |
| Interaction | YWHAB interactions | FOXO1 MTMR12 KSR2 RIPK2 CRTC1 ALS2 PPEF1 TRIP12 TRIP11 MAP3K3 IQGAP1 GRIP1 FAM171A1 DST GCC2 CCSER2 CD74 FGFR2 TP53BP2 | 2.75e-04 | 1014 | 154 | 19 | int:YWHAB |
| Interaction | PHF21A interactions | 3.15e-04 | 343 | 154 | 10 | int:PHF21A | |
| Interaction | SSH2 interactions | 3.21e-04 | 43 | 154 | 4 | int:SSH2 | |
| Interaction | LMBR1L interactions | FLNA TBC1D9B EVC2 ATP6V0A1 SPTLC1 PSMD2 LRRC40 CACHD1 TRIP12 DIPK2A IQGAP1 LRPPRC FAF2 GLE1 NUP133 PRKAR2A RHBDD3 CEP97 | 3.34e-04 | 946 | 154 | 18 | int:LMBR1L |
| Interaction | YWHAQ interactions | FOXO1 FLNA MTMR12 MYH13 KSR2 RIPK2 CRTC1 ALS2 TRIP12 TRIP11 DNAH7 MAP3K3 IQGAP1 GRIP1 FAM171A1 LRPPRC DST CCSER2 CD74 TP53BP2 | 3.43e-04 | 1118 | 154 | 20 | int:YWHAQ |
| Interaction | DSCAM interactions | 3.49e-04 | 171 | 154 | 7 | int:DSCAM | |
| Interaction | KCNA3 interactions | CCDC73 DSP ABCA13 MYO18A MPDZ PSMD2 LRRC40 CACHD1 ADCY9 IQGAP1 GRIP1 RABL6 FAM171A1 LRPPRC DST FAF2 ARHGAP29 | 3.69e-04 | 871 | 154 | 17 | int:KCNA3 |
| Interaction | KRT7 interactions | 3.70e-04 | 80 | 154 | 5 | int:KRT7 | |
| Interaction | BRK1 interactions | 3.84e-04 | 124 | 154 | 6 | int:BRK1 | |
| Interaction | LAMTOR1 interactions | ATP6V0A1 IQGAP2 ARHGAP17 NBEA CACHD1 TRIP11 ADCY9 IQGAP1 PRKD3 RABL6 FAM171A1 DST N4BP2 GCC2 DIAPH2 | 4.34e-04 | 722 | 154 | 15 | int:LAMTOR1 |
| Interaction | KRT15 interactions | 4.45e-04 | 178 | 154 | 7 | int:KRT15 | |
| Interaction | KRT76 interactions | 4.64e-04 | 84 | 154 | 5 | int:KRT76 | |
| Interaction | EIF3F interactions | 4.65e-04 | 296 | 154 | 9 | int:EIF3F | |
| Interaction | DISC1 interactions | FLNA TRIO SYNE1 RIBC1 FSD1 PPFIA3 TRIP11 DST N4BP2 PDE4DIP KRT37 | 4.72e-04 | 429 | 154 | 11 | int:DISC1 |
| Interaction | CEP128 interactions | TCHP DSP PPP1R13B MIPOL1 ODF2L CCSER2 ARHGAP29 CEP97 TP53BP2 | 4.77e-04 | 297 | 154 | 9 | int:CEP128 |
| Interaction | KRT75 interactions | 4.92e-04 | 181 | 154 | 7 | int:KRT75 | |
| Interaction | CLIP1 interactions | 5.25e-04 | 183 | 154 | 7 | int:CLIP1 | |
| Cytoband | 12q13.13 | 3.35e-06 | 67 | 155 | 5 | 12q13.13 | |
| GeneFamily | Keratins, type II | 5.04e-07 | 27 | 108 | 5 | 609 | |
| GeneFamily | Desmosomal cadherins | 7.28e-04 | 7 | 108 | 2 | 1188 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.67e-04 | 8 | 108 | 2 | 939 | |
| GeneFamily | Regulatory factor X family | 9.67e-04 | 8 | 108 | 2 | 1153 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 2.77e-06 | 67 | 154 | 6 | M40299 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_DN | CYP1B1 TRIO SYNE1 NR1H3 REV3L PARP4 DST MICAL2 PDE4DIP DIAPH2 | 8.90e-06 | 290 | 154 | 10 | M13251 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | IQGAP2 DSP CYP20A1 MYO18A PPP1R13B ARHGAP17 TRIP11 MAP3K3 DIPK2A PARP4 FRY SULF2 DST PDE4DIP DIAPH2 ARHGAP29 EML1 | 1.20e-05 | 854 | 154 | 17 | M1533 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SPAST ATRX TRIO CENPF KDM3B REV3L TRIP12 ADCY9 FAM171A1 LRPPRC DST MICAL2 GCC2 CCSER2 NUP133 ARHGAP29 TP53BP2 | 1.23e-05 | 856 | 154 | 17 | M4500 |
| Coexpression | BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS | 1.97e-05 | 140 | 154 | 7 | M40004 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | IQGAP2 DSP CYP20A1 MYO18A PPP1R13B ARHGAP17 TRIP11 MAP3K3 DIPK2A PARP4 FRY SULF2 DST PDE4DIP DIAPH2 ARHGAP29 EML1 | 1.97e-05 | 888 | 154 | 17 | MM1018 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATRX TRIO CENPF E2F2 REV3L TRIP12 FAM171A1 LRPPRC DST CCSER2 ARHGAP29 TP53BP2 | 2.13e-05 | 466 | 154 | 12 | M13522 |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 2.43e-05 | 199 | 154 | 8 | M7607 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 2.43e-05 | 199 | 154 | 8 | M5235 | |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP | 2.52e-05 | 200 | 154 | 8 | M3415 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 3.16e-05 | 102 | 154 | 6 | M5601 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 5.45e-05 | 13 | 154 | 3 | MM743 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 7.43e-05 | 300 | 154 | 9 | M8702 | |
| Coexpression | GU_PDEF_TARGETS_DN | 8.88e-05 | 40 | 154 | 4 | M10480 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | 9.19e-05 | 382 | 154 | 10 | M45756 | |
| CoexpressionAtlas | BM Top 100 - vagina | 1.52e-05 | 76 | 148 | 6 | BM Top 100 - vagina | |
| CoexpressionAtlas | BM Top 100 - tongue superior part w_papillae | 1.89e-05 | 79 | 148 | 6 | BM Top 100 - tongue superior part w_papillae | |
| CoexpressionAtlas | BM Top 100 - tongue main corpus | 2.04e-05 | 80 | 148 | 6 | BM Top 100 - tongue main corpus | |
| CoexpressionAtlas | BM Top 100 - esophagus | 3.08e-05 | 86 | 148 | 6 | BM Top 100 - esophagus | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.49e-05 | 230 | 148 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.96e-05 | 191 | 148 | 8 | gudmap_kidney_adult_Podocyte_MafB_k1_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 6.43e-05 | 98 | 148 | 6 | PCBC_ctl_BronchioEpithel_100 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.02e-08 | 197 | 154 | 9 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.15e-08 | 198 | 154 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.43e-08 | 200 | 154 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.43e-08 | 200 | 154 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-08 | 152 | 154 | 8 | 3b59143b2b4ee24eb6378f87ff568124193256e9 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-08 | 152 | 154 | 8 | d279592c501fca9cb474ad916fea32282e6969cb | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 3.36e-07 | 190 | 154 | 8 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.79e-07 | 193 | 154 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 195 | 154 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-07 | 196 | 154 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.26e-07 | 196 | 154 | 8 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-07 | 197 | 154 | 8 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.43e-07 | 197 | 154 | 8 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 4.43e-07 | 197 | 154 | 8 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-07 | 198 | 154 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.60e-07 | 198 | 154 | 8 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.96e-07 | 200 | 154 | 8 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-07 | 145 | 154 | 7 | 4f8b188a93a038afbc7a446df8467ad544f5b1cb | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.25e-06 | 171 | 154 | 7 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-06 | 179 | 154 | 7 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-06 | 181 | 154 | 7 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-06 | 181 | 154 | 7 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 184 | 154 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.65e-06 | 184 | 154 | 7 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 184 | 154 | 7 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 184 | 154 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 184 | 154 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-06 | 186 | 154 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.06e-06 | 187 | 154 | 7 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.21e-06 | 188 | 154 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 188 | 154 | 7 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col6a1_Fezf2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.25e-06 | 122 | 154 | 6 | e96aec5af0ed1d8f4cc99fde59dd6998bbc1acbd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.36e-06 | 189 | 154 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.83e-06 | 192 | 154 | 7 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 4.83e-06 | 192 | 154 | 7 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.17e-06 | 194 | 154 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-06 | 195 | 154 | 7 | 6a0460d949ccda7c9fe76870d3ee6c2f60677d61 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-06 | 195 | 154 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 1d4ccca2ff46fccb3ac052b5148cb7f94231d65a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | distal-1-Epithelial-Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.72e-06 | 197 | 154 | 7 | 25a2ccc98b973611de0d920b1b455d0b40f0d37f | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.72e-06 | 197 | 154 | 7 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.72e-06 | 197 | 154 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-06 | 197 | 154 | 7 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.91e-06 | 198 | 154 | 7 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.91e-06 | 198 | 154 | 7 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | Healthy_donor-gd_T|Healthy_donor / disease group, cell group and cell class (v2) | 5.91e-06 | 198 | 154 | 7 | 25158815287efbdd8f463baa755cbb874f3905f3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-06 | 198 | 154 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-06 | 198 | 154 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.91e-06 | 198 | 154 | 7 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.91e-06 | 198 | 154 | 7 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-06 | 198 | 154 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.91e-06 | 198 | 154 | 7 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.11e-06 | 199 | 154 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.11e-06 | 199 | 154 | 7 | dfdf551a292e33e3ee356629fa48a0a2f009624d | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 6.11e-06 | 199 | 154 | 7 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.11e-06 | 199 | 154 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | distal-1-Epithelial-Proliferating_Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.11e-06 | 199 | 154 | 7 | 93450257180d918c310bca7b5defc74390c48091 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.11e-06 | 199 | 154 | 7 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.11e-06 | 199 | 154 | 7 | ec7a1b0b71175b3a4015522bf88784eb176d59e3 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.31e-06 | 200 | 154 | 7 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.31e-06 | 200 | 154 | 7 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | distal-Epithelial-Proliferating_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.31e-06 | 200 | 154 | 7 | 25cc494ef831511840d8c02ec1bd086635cc7edd | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.31e-06 | 200 | 154 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 6.31e-06 | 200 | 154 | 7 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-06 | 200 | 154 | 7 | 580fbf9fcb78357a081e5f5af06113ca33d44581 | |
| ToppCell | distal-Epithelial-Proliferating_Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.31e-06 | 200 | 154 | 7 | cc31e8c28d01e6757c5dd7f485db6acf7409a47e | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK|COVID-19_Mild / Disease group, lineage and cell class | 6.31e-06 | 200 | 154 | 7 | e69416952039ca076e9b71187d8783fe567ee873 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK|COVID-19_Mild / Disease, condition lineage and cell class | 6.31e-06 | 200 | 154 | 7 | 6d9796153d038329a820949c0b88fd01265a1227 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.31e-06 | 200 | 154 | 7 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Rrad|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.64e-06 | 138 | 154 | 6 | b3a040c5d0e1cc94d9b19155bca8700edba2d243 | |
| ToppCell | facs-Heart-LA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 161 | 154 | 6 | 248487415a0601d57ef2a6692e22a61368d0b9c8 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-05 | 162 | 154 | 6 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 166 | 154 | 6 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-05 | 168 | 154 | 6 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-05 | 169 | 154 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 2.91e-05 | 171 | 154 | 6 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 3.01e-05 | 172 | 154 | 6 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.11e-05 | 173 | 154 | 6 | 1b2508cc890430bd4b2cf232c633928edb86c57e | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.21e-05 | 174 | 154 | 6 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 174 | 154 | 6 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 174 | 154 | 6 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 174 | 154 | 6 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-05 | 174 | 154 | 6 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 174 | 154 | 6 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 177 | 154 | 6 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-05 | 179 | 154 | 6 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.76e-05 | 179 | 154 | 6 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.76e-05 | 179 | 154 | 6 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.76e-05 | 179 | 154 | 6 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.88e-05 | 180 | 154 | 6 | 535a890bde0d978b461c2d4c571529b585c76b21 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 182 | 154 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 182 | 154 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 4.13e-05 | 182 | 154 | 6 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.25e-05 | 183 | 154 | 6 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.25e-05 | 183 | 154 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 184 | 154 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.52e-05 | 185 | 154 | 6 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| Computational | Intermediate filaments and MT. | 2.97e-06 | 68 | 100 | 7 | MODULE_438 | |
| Computational | Genes in the cancer module 68. | 3.55e-06 | 26 | 100 | 5 | MODULE_68 | |
| Computational | Keratin. | 3.55e-06 | 26 | 100 | 5 | MODULE_298 | |
| Computational | Genes in the cancer module 248. | 1.93e-04 | 129 | 100 | 7 | MODULE_248 | |
| Computational | Genes in the cancer module 153. | 2.64e-04 | 34 | 100 | 4 | MODULE_153 | |
| Drug | plakin | 8.95e-08 | 82 | 155 | 8 | CID000018752 | |
| Drug | MK-6 | 5.25e-07 | 24 | 155 | 5 | CID005283547 | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | FOXO1 IL12A ATP6V0A1 MED16 CYP20A1 FRS3 PPP1R13B PCNX2 PDE4DIP DIAPH2 | 1.19e-06 | 200 | 155 | 10 | 2148_UP |
| Drug | teleocidin B | 2.04e-06 | 123 | 155 | 8 | CID000072425 | |
| Drug | sulfur mustard | 3.10e-06 | 130 | 155 | 8 | CID000010461 | |
| Drug | SC-791 | 6.10e-06 | 6 | 155 | 3 | CID010291510 | |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; HL60; HT_HG-U133A | CYP1B1 KRT6B ATP6V0A1 MED16 MICAL2 GLE1 PDE4DIP DIAPH2 FGFR2 | 8.93e-06 | 198 | 155 | 9 | 2505_UP |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A | ATP6V0A1 CYP20A1 CRTC1 MAP3K6 TRIP11 PCNX2 PDE4DIP RHBDD3 FGFR2 | 8.93e-06 | 198 | 155 | 9 | 1506_DN |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; PC3; HT_HG-U133A | 8.93e-06 | 198 | 155 | 9 | 7299_UP | |
| Drug | AC1L9LMC | 2.21e-05 | 83 | 155 | 6 | CID000448113 | |
| Drug | mant-GTP | 2.27e-05 | 50 | 155 | 5 | CID000128647 | |
| Drug | 1-2q | 3.02e-05 | 289 | 155 | 10 | CID000011820 | |
| Drug | homocysteine thiolactone | 3.26e-05 | 131 | 155 | 7 | CID000107712 | |
| Drug | DIMIT | 3.96e-05 | 56 | 155 | 5 | CID000006624 | |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 4.06e-05 | 185 | 155 | 8 | 7209_DN | |
| Drug | diars | 4.60e-05 | 2 | 155 | 2 | CID000083261 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 4.91e-05 | 190 | 155 | 8 | 6199_UP | |
| Drug | AC1L9MJT | 5.29e-05 | 192 | 155 | 8 | CID000448959 | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A | 5.69e-05 | 194 | 155 | 8 | 3689_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.89e-05 | 195 | 155 | 8 | 6927_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.89e-05 | 195 | 155 | 8 | 6868_DN | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A | 5.89e-05 | 195 | 155 | 8 | 1184_UP | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 6174_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; PC3; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 4508_UP | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 2749_UP | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; PC3; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 6694_DN | |
| Drug | Norethindrone [68-22-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 7414_DN | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; HL60; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 2155_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 4995_DN | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; HL60; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 6160_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; HL60; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 2714_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; HL60; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 6178_UP | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 6.56e-05 | 198 | 155 | 8 | 1009_DN | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 6.80e-05 | 199 | 155 | 8 | 6188_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 6.80e-05 | 199 | 155 | 8 | 3531_DN | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; HL60; HT_HG-U133A | 6.80e-05 | 199 | 155 | 8 | 2454_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; HL60; HT_HG-U133A | 7.04e-05 | 200 | 155 | 8 | 2905_DN | |
| Drug | diacetylene | 1.07e-04 | 14 | 155 | 3 | CID000009997 | |
| Disease | Malignant neoplasm of breast | CYP1B1 FLNA KRT5 TBC1D9B SPAST CENPF SYNE1 SPTLC1 C4orf50 RFX2 MAP3K6 STAT4 SULF2 N4BP2 NUP133 ARHGAP29 CD74 FGFR2 TP53BP2 | 2.65e-06 | 1074 | 151 | 19 | C0006142 |
| Disease | Intellectual Disability | DEAF1 TRIO DOCK8 SYNE1 NR4A2 KDM3B NBEA CHD8 RABL6 PNPT1 FRY FGFR2 | 3.54e-06 | 447 | 151 | 12 | C3714756 |
| Disease | Familial bent bone dysplasia syndrome | 2.60e-05 | 2 | 151 | 2 | cv:CN322353 | |
| Disease | Severe dermatitis, multiple allergies, metabolic wasting syndrome | 2.60e-05 | 2 | 151 | 2 | C3809719 | |
| Disease | EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE (disorder) | 7.78e-05 | 3 | 151 | 2 | C1832926 | |
| Disease | Striate palmoplantar keratoderma | 7.78e-05 | 3 | 151 | 2 | C4707237 | |
| Disease | Profound Mental Retardation | 8.34e-05 | 139 | 151 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 8.34e-05 | 139 | 151 | 6 | C0025363 | |
| Disease | Mental deficiency | 8.34e-05 | 139 | 151 | 6 | C0917816 | |
| Disease | Pachyonychia congenita syndrome | 1.55e-04 | 4 | 151 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.55e-04 | 4 | 151 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.55e-04 | 4 | 151 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.55e-04 | 4 | 151 | 2 | C1721007 | |
| Disease | diaphragmatic hernia | 1.63e-04 | 21 | 151 | 3 | EFO_0008561 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 2.58e-04 | 5 | 151 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | Pachyonychia Congenita | 2.58e-04 | 5 | 151 | 2 | C0265334 | |
| Disease | Epidermolysis Bullosa Simplex | 2.58e-04 | 5 | 151 | 2 | C0079298 | |
| Disease | glycerol measurement | 3.13e-04 | 26 | 151 | 3 | EFO_0010115 | |
| Disease | Polydactyly | 3.47e-04 | 117 | 151 | 5 | C0152427 | |
| Disease | anxiety, vitamin D measurement | 5.37e-04 | 7 | 151 | 2 | EFO_0004631, EFO_0005230 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 5.37e-04 | 7 | 151 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | inter-alpha-trypsin inhibitor heavy chain H1 measurement | 5.37e-04 | 7 | 151 | 2 | EFO_0801705 | |
| Disease | Disproportionate short stature | 6.67e-04 | 77 | 151 | 4 | C0878659 | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 7.14e-04 | 8 | 151 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | thiamine measurement | 1.14e-03 | 10 | 151 | 2 | EFO_0010540 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | primary biliary cholangitis (is_implicated_in) | 1.14e-03 | 10 | 151 | 2 | DOID:12236 (is_implicated_in) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | unipolar depression, bipolar disorder | 1.28e-03 | 156 | 151 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Neurodevelopmental Disorders | 1.35e-03 | 93 | 151 | 4 | C1535926 | |
| Disease | craniosynostosis (is_implicated_in) | 1.66e-03 | 12 | 151 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.66e-03 | 12 | 151 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.66e-03 | 12 | 151 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.92e-03 | 48 | 151 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | X-11444 measurement | 1.96e-03 | 13 | 151 | 2 | EFO_0021237 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.96e-03 | 13 | 151 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Vitiligo, response to rhododendrol | 1.96e-03 | 13 | 151 | 2 | EFO_0004208, EFO_0010824 | |
| Disease | Sjogren's Syndrome | 1.96e-03 | 13 | 151 | 2 | C1527336 | |
| Disease | esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement | 1.96e-03 | 13 | 151 | 2 | EFO_0000280, EFO_0000478, EFO_0008343 | |
| Disease | Sicca Syndrome | 1.96e-03 | 13 | 151 | 2 | C0086981 | |
| Disease | Hamman-Rich syndrome | 2.27e-03 | 14 | 151 | 2 | C0085786 | |
| Disease | Hiatus hernia | 2.27e-03 | 14 | 151 | 2 | HP_0002036 | |
| Disease | Hernia | 2.29e-03 | 51 | 151 | 3 | HP_0100790 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.61e-03 | 15 | 151 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Keratoderma, Palmoplantar | 2.98e-03 | 16 | 151 | 2 | C4551675 | |
| Disease | Abnormal behavior | 2.98e-03 | 16 | 151 | 2 | C0233514 | |
| Disease | neuroblastoma | 3.03e-03 | 116 | 151 | 4 | EFO_0000621 | |
| Disease | alcoholic liver cirrhosis | 3.36e-03 | 17 | 151 | 2 | EFO_1000802 | |
| Disease | unipolar depression | OTOA MYH13 CCDC73 TRIO ABCA13 PCLO NR4A2 TRIP11 DNAH7 AQP7 VNN2 MICAL2 ERC2 EML1 | 3.68e-03 | 1206 | 151 | 14 | EFO_0003761 |
| Disease | nevus count | 3.77e-03 | 18 | 151 | 2 | EFO_0004632 | |
| Disease | Usual Interstitial Pneumonia | 4.20e-03 | 19 | 151 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.20e-03 | 19 | 151 | 2 | C4721508 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 4.65e-03 | 20 | 151 | 2 | C4721952 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNDSLQSISLMNAEV | 356 | P60509 | |
| ADLDMDLLNSKNNLV | 1381 | Q9HCK8 | |
| DSKTLQEQMDELLQQ | 256 | P41214 | |
| QLDMLDLSNNSLASV | 261 | P02750 | |
| ADLVLANQQIMSQIL | 2981 | Q9NR09 | |
| QREIEDLTQQLAAMQ | 491 | A8MYA2 | |
| AVELQDMSLLSIQQQ | 91 | Q8NI51 | |
| LQDLSEVNDENTQLM | 816 | Q96Q42 | |
| QMLESVLLELQNFSE | 131 | Q9H116 | |
| SMARINVSLLDINDN | 671 | Q6V0I7 | |
| NEENSFLNNSVMILT | 366 | Q5VU97 | |
| DLLVDQLEQVSVNLM | 1676 | Q86UQ4 | |
| LQEEMLQLSQQLDAS | 251 | Q53GS7 | |
| FVNLMESTLQQELDS | 326 | Q9P1Z9 | |
| LEVNEDMLSEALIQN | 736 | O60879 | |
| LTLSELQDMAARQQQ | 126 | Q96KQ4 | |
| LTLAELQEMASRQQQ | 126 | Q13625 | |
| RSNQQLENDLNLMDI | 901 | P46940 | |
| DNLLQDDQNILLEDM | 216 | Q9H4I0 | |
| SMLLENLTDNESENT | 131 | Q9ULJ1 | |
| NQLDMDATLEELSVQ | 246 | Q3YEC7 | |
| LNMIVAVIDSAQLQE | 761 | Q68E01 | |
| NVQELIIAADMLQLT | 106 | Q9Y573 | |
| MNELQLNDAEFALLI | 346 | Q13133 | |
| ELLDIAMENQTLNET | 386 | Q7RTW8 | |
| IEENSASNSLVMILN | 166 | P32926 | |
| DLAARNVLVTENNVM | 626 | P21802 | |
| SQSNLMPDLNLNEQE | 236 | Q92585 | |
| ILVQMCEQTDNQSRL | 871 | Q8WUM0 | |
| AALAQMNSEVQLLTE | 676 | Q5VUB5 | |
| SMDNNRNLDLDSIIA | 321 | P48668 | |
| AFQNLEIELQSQLAM | 351 | Q99456 | |
| NTQLVLETLAQMDDL | 551 | P19823 | |
| ENDMTLQELLNRINN | 216 | Q8TD10 | |
| SMDNNRNLDLDSIIA | 321 | P02538 | |
| EAQNMNVLLLEENAS | 381 | Q9C0I1 | |
| DLIDMNTVAVQSNLA | 196 | Q03001 | |
| SSLLDQNLTEEEINM | 591 | Q03001 | |
| NSDENENINTMILLD | 2636 | Q03001 | |
| ELLETANQTLQAMDS | 96 | Q9BTV5 | |
| QMQSLISNLEEQLSE | 361 | O76014 | |
| QADVQTLAIMLQEQL | 596 | O75145 | |
| SMDNNRNLDLDSIIA | 326 | P13647 | |
| LQQCELVQNMIDLSI | 21 | Q6VAB6 | |
| SVVLSMDNNRNLDLD | 291 | P19013 | |
| QELNVDSGTIQMLLN | 1226 | O95382 | |
| QLQELENKDLSDVAM | 781 | Q86VH2 | |
| VRLDLNMLSDSENSQ | 4586 | Q9Y6V0 | |
| ILDNNAATMLQVFDL | 1511 | A6NKB5 | |
| SMDNNRNLDLDSIIA | 321 | P04259 | |
| MDLESLEAANQSLQA | 1906 | Q92614 | |
| AVDATIDQLLQMNLE | 76 | Q9NWM3 | |
| MADRLTQLQDAVNSL | 1 | Q13503 | |
| LFQMGTDSQNQILLE | 156 | Q7LBC6 | |
| QQNSVVLEDLLENME | 1096 | Q86UK5 | |
| MNSENILQLITSADE | 116 | O94806 | |
| NNIDAAIENIENMLT | 1191 | P42704 | |
| MLQLCLFAITDQENN | 181 | O14520 | |
| NSQHLQIEELMNALE | 796 | O15083 | |
| AVIDELMQALNFNSE | 161 | P29459 | |
| LANSTALEEAMLQEQ | 2566 | O15230 | |
| ASEQLQALLLEEVMN | 241 | Q9UKK3 | |
| LAELLNSNVANDLML | 1346 | Q8NDA8 | |
| IEENSNANTLVMILN | 166 | Q02413 | |
| NANTLVMILNATDAD | 171 | Q02413 | |
| TEEFVLDMNTLQALQ | 601 | Q9Y2X0 | |
| DVLQQIMAITDQSLD | 21 | Q9BYU1 | |
| LNSVDLQNAAEMLTA | 96 | Q52LW3 | |
| ESSEMNSIDILNNLE | 531 | Q9H7U1 | |
| AITQLANVDEVNQIM | 66 | Q15825 | |
| NMNLSEAQVQALALS | 2361 | P46100 | |
| NLLLSELAQNMLNDV | 106 | Q6ZRC1 | |
| TEMASLLSLQEENQL | 71 | Q5TZA2 | |
| SLAQVNAMLREQLDQ | 231 | Q5TZA2 | |
| SNPENMENLLDNLNL | 366 | Q12778 | |
| ELMNTEQALDQLIQS | 216 | Q14209 | |
| IILDMQENIIQASSA | 1436 | Q8NF50 | |
| NQNLMLELETVQQAL | 1096 | P49454 | |
| LLEETQLDMNEFDNL | 146 | Q8IWX8 | |
| TQAVAMDALSLEQQL | 336 | Q6UUV9 | |
| LEEMVNSLLNTAQQL | 456 | O75398 | |
| QMQLENVSVALEFLD | 101 | P21333 | |
| LASLTELEQLSIMNN | 191 | Q8IW35 | |
| EIFNLLQDLMQCNSI | 96 | O43559 | |
| QLMEIAEQLTNNDFE | 266 | Q8NDZ4 | |
| FAQANDQMEILDSLI | 111 | P15924 | |
| LRQQIQANTEMEAEL | 291 | Q6ZRK6 | |
| QLQDLTLVSMQDFTD | 371 | Q8WXX0 | |
| LEEAMNTQLELSEQL | 156 | Q8IWJ2 | |
| SNDVNLANLMEQLGV | 511 | O60503 | |
| QAQEQRITALENMLC | 451 | Q6QEF8 | |
| KNLDQEQLSQVLDAM | 141 | P13861 | |
| MELLDSAVQNLQAKE | 526 | Q16678 | |
| ELDQQLNDLESCVMQ | 111 | P32881 | |
| QMQEDDIQLLKSALA | 46 | O00423 | |
| NTIQTMEELLFELQQ | 1486 | Q5TBA9 | |
| VMDDQRDLISNNEQL | 16 | P04233 | |
| LNDQQILEDSMIFSL | 261 | Q6UW02 | |
| LDNCSMEDAVQILQQ | 631 | Q9Y3R0 | |
| LSMENSQALEQINVR | 306 | Q13474 | |
| MENLTTLDLQNNDLL | 541 | Q9H9A6 | |
| MNNELSILLKNQDDL | 86 | Q99759 | |
| TEMLLCAENVNQDNL | 321 | O94851 | |
| IDDSQVNKLANIMDL | 606 | O14829 | |
| IVEFSSNLQNMNIDI | 486 | P43354 | |
| MILLNTEDLASLNND | 946 | A6NKG5 | |
| QQELEMVESLLSLAN | 226 | Q9H668 | |
| IQNALGSDIIMQLDD | 146 | Q9BXR0 | |
| MASLLQDQLTTDQDL | 1 | Q9BRC7 | |
| QDQLTTDQDLLLMQE | 6 | Q9BRC7 | |
| QHQNQSLSMLDEILE | 171 | Q6UWJ1 | |
| MLTLENDQSLSFEAQ | 241 | Q8N103 | |
| SELELNIAQNMVSQV | 4161 | Q8NF91 | |
| LMLQDEINELQSSLA | 6011 | Q8NF91 | |
| TSQINQMLSDLNRVD | 531 | P48378 | |
| TSQINQMLSDLNRVD | 516 | P48380 | |
| QNMQEASTQLEDSLL | 76 | Q68EM7 | |
| DLTEIMSNVQLNSNF | 316 | Q13200 | |
| MLSAVALLNQALESN | 371 | Q13576 | |
| QIKDLQMQLDDSTQL | 1661 | Q9Y2K3 | |
| SQAIVNQNAETELML | 2116 | Q8NFP9 | |
| DDLINQLTFIMDANQ | 256 | Q96CS3 | |
| TFNALVELLNMEIDN | 181 | Q5VSL9 | |
| MIDSSSAQNLELLIN | 311 | O15457 | |
| DSNLANLIMNEIVDN | 321 | Q9UBP0 | |
| IVMLEASAENILQQD | 226 | Q8TCS8 | |
| NIDDIDLISANMENA | 296 | O15269 | |
| LTDIEDMLQLINNQD | 26 | P36956 | |
| QVALAVLDANMEQLL | 701 | Q66K14 | |
| ADIQAMEDSLLQIQD | 311 | Q9C0B6 | |
| INEMNELNISSLQIA | 261 | A6NHY2 | |
| NANSEIQMLNASLET | 221 | Q8N1N0 | |
| QMDINAAIQALIESN | 1481 | Q17RW2 | |
| AAIQALIESNTALQM | 1486 | Q17RW2 | |
| ALDELASLQVTMQQA | 376 | O75475 | |
| ALDEQMLQEGIQASL | 291 | Q9Y3P4 | |
| ALNEEMELNLSQLQE | 231 | Q86WT6 | |
| SQEDALNLMNENIDI | 46 | O95498 | |
| TDALSNQLRLAMDAQ | 181 | Q8N443 | |
| LMFVNDVNLENSSLE | 751 | O75970 | |
| LQNTMVNLALENACD | 96 | P11217 | |
| LINEEAILNLMENSQ | 376 | O60673 | |
| DLLDQMAAELQQDVA | 1551 | Q8IWN7 | |
| DLEETFENLILNQMN | 466 | Q8WU10 | |
| QLQSELLNIESQCIM | 736 | Q8NDV3 | |
| DAMNNIVANLLLNLT | 256 | Q9UJT0 | |
| VNQEVLTLQEMLNSL | 191 | Q14765 | |
| DIVNQMTEACLNQSL | 446 | O43353 | |
| LQLQVQSETENLMDA | 891 | Q9UKX3 | |
| LTMANQVLAVNISEE | 596 | Q9NY15 | |
| SNMSFEELLELQSQV | 46 | Q96EU6 | |
| EQLSDALLQQEAETM | 466 | Q9BT92 | |
| VNTRIDDLQMVLNQT | 261 | Q93050 | |
| QQALSDAENEIMRLS | 391 | Q15643 | |
| HLDLNQDNIQVMLDT | 86 | Q6ZSB9 | |
| INQQLSLESMELDEL | 61 | Q96LX8 | |
| ESQQLQAVIEMCQLL | 451 | Q14669 | |
| MSENLNAELVTFAQE | 1261 | Q6ZQQ6 | |
| LMNAVNTLDRDVLNQ | 791 | Q8IWU5 | |
| LQQLDEAQSQMEELF | 761 | O75962 | |
| LLQLQNTDELDFMSS | 96 | Q13241 | |
| MQLTEDLDSLIQNAF | 136 | Q86UW6 | |
| VVSLAEAQQELQMLQ | 1736 | Q5VU43 |